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The bacterial cell wall is fortified by the biopolymer murein (pep- 
tidoglycan), a meshwork of glycan strands that are cross-linked by 
peptide bridges. The murein layer forms a covalently closed string- 
bag-like structure, called sacculus. Thus, p w t h  of a bacterium de- 
pends on the simultaneous enlargement of its murein sacculus. In or- 
der to enlarge the murein netting the concerted activities of enzymes 
cleaving meshes and e n m e s  inserting new subunits, that is murein 
hydrolases and synthases, are needed. Most important however, the 
murein hydrolases must not act separately to avoid dissolution of 
the stress-bearing sacculus and hence bacteriolysis. Recent experi- 
mental results indicate that one way of controlling the potentially 
autolytic murein hydrolases seems to be their integration within a 
multienzyme complex, a murein synthesizing machmery combining 
both hydrolases and syntheses. Accordingly, any block in the sup- 
ply of activated murein precursors will result in an idling of the 
machinery with the murein hydrolases degradmg the murein. Bac- 
teriolysis is indeed the hallmark of most murein synthesis inhibitors. 
The conception of a murein synthesizing machinery suggests a novel 
target for antibiotics. Compounds interfering with the assembly of a 
functional machinery are expected to block further enlargement of 
the sacculus and moreover are likely to induce autolysis due to the 
missing control of the hydrolases by the complex. 
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Massachusetts General Hospital, H a m r d  Medical School, Boston, MA, 
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DNA gyrase w&originally identified as a target of 4-quinolones 
&om resistance mutations in W A  and later gyB,  the genes encoding 
the two enzyme subunits, GyrA and GyrB, in Escheriskia coli. The 
clustering of resistance mutations within domains of GyrA and GyrB 
and the reduction in binding of quinolones to resistant gyrase-DNA 
complexes indicated that resistance was mediated by enzyme changes 
that reduced drug binding af2inity Recent models based on the crys- 
tal structure of the yeast topoisomerase I1 homolog localize altered 
amino acids of mutant GyrA near the site of DNA strand breakage 
and suggest a means for drug binding to antagonize enzyme func- 
tion and trap DNA deavage intermediates. Altered amino acids of 
mutant GyrB, however, are distantly placed from those in GyrA and 
from the jaws of the proposed clamps involved in DNA strand pas- 
sage, leaving unclear how these changes might effect resistance. More 
recently topoisomerase IV, a homolog of DNA gyrase encoded by 
the parC and parE genes, has been identified as a quinolone target. 
Resistance mutations in parC and parE in regions sunilar to those 
of gyrA and ~ y r B  have been found. parC and parE mutations in E.  
coli, however, cause resistance to ciprofloxacin only in the presence 
of resistant gyrase, indcating that topoisomerase IV is a secondary 
target of ciprofloxacin. In S. auras and Streptococcus pneumoniae, in 
contrast, parC mutations alone are sufficient to cause low-level resis- 
tance, and gyrA mutations cause ciprofloxacin resistance only in the 
presence of resistant topoisomerase rV, indicating that topoisomerase 
IV is the principal target. In recent work by others the sensitivity 
of the enzymes purified from E .  coli and S. aureus indmted that 
species-specific Merences in the primary targets of ciprofloxacin are 
likely determined by the enzyme with the most drug sensitivity. 
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Switzerland 
Methidm resistance in Staphyloroccus aureus is due to the acquisition 
of an additional, low &ty penidin-bindmg protein, PBPZ', that 
adds to the resident four PBPs of the cells. This foreign PBPZ' needs 
specific conditions for optimal expression of methicillin resistance. . 
Any changes in the balance or chemistry of peptidoglycan precursor 
formation has usually negative effects on the ability of PBPZ' to 
confer methidm resistance. The most important role plays thereby 
the characteristic pentaglycine side-chain (Glyl-5) that is attached to 
the peptidoglycan stem-peptide. It functions as acceptor in the PBP 
catalysed transpeptidase reaction. Its length and flexibihty allows a 
high cross-linking between the peptidoglycan strands that form the 
murein sacculus. Shortening of rhis side-chain abolishes methicillin 
resistance. The proteins involved in the addition of Gly2-Gly3 and 
of Gly4-Gly5 have been identified as F e d  and F e d ,  respectively. 
They are encoded by the f d B  operon. Although f e d B  Null 
mutants are still viable under laboratory conditions, their growth is 
strongly impaired. They are hypersusceptible to a l l  &lactams as well 
as to aIl other classes of antibiotics. F e d  and FemB are therefore 
potential targets for new antibacterial agents that may restore the 
efficacy of b-lactams against methicillin resistant S. aurm.  A fuaher 
promising drug-target is the not yet identified F e d ,  postulated to 
catalyse the attachment of the first glycine residue of the side-chain 
to the stem-peptide. 
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Rapid Identification of Clinically Relevant 
Gram-Negative Rods 
J. Bille. University Hospital, Lausanne, Switzerland 
Rapid identification of pathogenic bacteria is important chcally 
because it can offer clues toward antibiotic resistance, the route of 
mfection, and have an impact on patient care. 
From more than 130 species of Enterobacteriaceae known today, 
